Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Travere Therapeutics Inc (NQ: TVTX ) 17.69 +0.25 (+1.43%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Travere Therapeutics Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > 12 Health Care Stocks Moving In Tuesday's Intraday Session December 05, 2023 Via Benzinga What's Going On With Travere Therapeutics Stock? December 05, 2023 Travere Therapeutics, Inc. (NASDAQ: TVTX) shares are trading higher Tuesday. Via Benzinga Travere Therapeutics Inc. (NASDAQ: TVTX) Near the Top of Equities by Percentage Gain on 12/5 December 05, 2023 Via Investor Brand Network NIO Reports Q3 Results, Joins Hovnanian Enterprises, Signet Jewelers And Other Big Stocks Moving Higher On Tuesday December 05, 2023 U.S. stocks traded mostly lower, with the Dow Jones index falling more than 100 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's After-Market Session December 04, 2023 Via Benzinga Where Travere Therapeutics Stands With Analysts November 20, 2023 Via Benzinga Preview: Travere Therapeutics's Earnings November 06, 2023 Via Benzinga Expert Ratings for Travere Therapeutics September 22, 2023 Via Benzinga Travere Completes Successful pre-NDA Meeting for FILSPARI in IgAN; Provides Regulatory Updates for both IgAN and FSGS December 04, 2023 From Travere Therapeutics, Inc. Via GlobeNewswire Travere Therapeutics to Present at the 6th Annual Evercore ISI HealthCONx Conference November 21, 2023 From Travere Therapeutics, Inc. Via GlobeNewswire Travere Therapeutics Reports Third Quarter 2023 Financial Results November 07, 2023 From Travere Therapeutics, Inc. Via GlobeNewswire Travere Therapeutics Announces Late-Breaking Data from Phase 3 Studies of Sparsentan in IgAN and FSGS Published in The Lancet and The NEJM Respectively and Presented at the American Society of Nephrology (ASN) Kidney Week 2023 November 03, 2023 From Travere Therapeutics, Inc. Via GlobeNewswire Earnings Scheduled For November 7, 2023 November 07, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. Via Benzinga Travere Therapeutics to Report Third Quarter 2023 Financial Results October 24, 2023 From Travere Therapeutics, Inc. Via GlobeNewswire Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023 October 13, 2023 From Travere Therapeutics, Inc. Via GlobeNewswire Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 11, 2023 From Travere Therapeutics, Inc. Via GlobeNewswire Travere Therapeutics, Inc. (NASDAQ:TVTX) Shareholder Notice: Investigation over Possible Breaches of Fiduciary Duties September 29, 2023 San Diego, CA -- (SBWIRE) -- 09/29/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Travere Therapeutics, Inc. Via SBWire Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023) September 26, 2023 From Travere Therapeutics, Inc. Via GlobeNewswire Micron Technology To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Friday September 22, 2023 Loop Capital increased the price target for Splunk Inc. (NASDAQ: SPLK) from $135 to $157. Loop Capital analyst Yun Kim downgraded the stock from Buy to Hold. Splunk shares fell 0.1% to $144.25 in... Via Benzinga Back To Back Trial Failures: Analyst Weighs In On Travere Therapeutics' Prospects, Challenges September 21, 2023 William Blair downgraded Travere Therapeutics Inc (NASDAQ: TVTX) Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023 September 22, 2023 Via Benzinga Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit September 21, 2023 U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 200 points on Thursday. The Dow traded down 0.58% to 34,239.48 while the NASDAQ fell 1.20% to 13,307.77. The S&P... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Thursday's Intraday Session September 21, 2023 Via Benzinga Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session September 21, 2023 Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday. Via Benzinga Why Shares of Travere Therapeutics Are Slumping Thursday September 21, 2023 A mixed trial could hurt a kidney drug's chances of full approval. Via The Motley Fool Why Former Highflier Travere Therapeutics Just Crashed 41% To A Decade-Low September 21, 2023 It's now up to the FDA whether the company's key drug remains on the market. Via Investor's Business Daily Exposures Product Safety Stocks That Hit 52-Week Lows On Thursday September 21, 2023 During the session on Thursday, 461 stocks hit new 52-week lows. Via Benzinga Gold Down Over 1%; FedEx Shares Rise On Earnings Beat September 21, 2023 U.S. stocks traded lower midway through trading, with the Dow Jones falling around 150 points on Thursday. The Dow traded down 0.46% to 34,284.15 while the NASDAQ fell 1.05% to 13,327.80. The S&P 500... Via Benzinga Topics Stocks Exposures US Equities Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected September 21, 2023 U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.56% to 34,248.45 while the NASDAQ fell... Via Benzinga Topics Stocks Exposures US Equities Why Is Kidney-Disease Focused Travere Therapeutics Stock Trading Lower Today? September 21, 2023 Travere Therapeutics Inc (NASDAQ: TVTX) announced Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.